Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mullany, P.
Right arrow Articles by Tabaqchali, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mullany, P.
Right arrow Articles by Tabaqchali, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1995) 35, 305-315
© 1995 The British Society for Antimicrobial Chemotherapy


research-article

Transfer of macrolide-lincosamide-streptogramin B (MLS) resistance in Clostridium difficile is linked to a gene homologous with toxin A and is mediated by a conjugative transposon, Tn5398

P. Mullany, M. Wilks and S. Tabaqchali

Department of Medical Microbiology, St Bartholomew's Hospital Medical College West Smithfield, London EC1A 7BE, UK

Received 19 November 1993; returned 3 May 1994; accepted 26 September 1994


An MLS resistance gene designated ermBZ, from a toxigenic Clostridium difficile strain (630) could be transferred between C. difficile strains, and to and from Bacillus subtilis. The intergeneric transfer occurred in the absence of any detectable plasmid DNA and the element responsible for gene transfer entered the recipient's chromosome, behaviour which is characteristic of a conjugative transposon. The element was designated Tn5398 and was found in six C. difficile strains. Tn5398 could be transferred to the non-toxigenic strain C. difficile CD37 which lacks the genes for toxins A and B. Transconjugants from both C. difficile and B. subtilis that had received the ermBZ gene also acquired a sequence of DNA that was homologous to the part of the toxin A gene that coded for the C-terminal repeat region.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
C. V. Hawkyard and R. J. Koerner
The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks
J. Antimicrob. Chemother., March 1, 2007; 59(3): 347 - 358.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
H. Pituch, J. S. Brazier, P. Obuch-Woszczatynski, D. Wultanska, F. Meisel-Mikolajczyk, and M. Luczak
Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance
J. Med. Microbiol., February 1, 2006; 55(2): 207 - 213.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
H. A Hussain, A. P Roberts, and P. Mullany
Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630{Delta}erm) and demonstration that the conjugative transposon Tn916{Delta}E enters the genome of this strain at multiple sites
J. Med. Microbiol., February 1, 2005; 54(2): 137 - 141.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
R. J. van den Berg, E. C. J. Claas, D. H. Oyib, C. H. W. Klaassen, L. Dijkshoorn, J. S. Brazier, and E. J. Kuijper
Characterization of Toxin A-Negative, Toxin B-Positive Clostridium difficile Isolates from Outbreaks in Different Countries by Amplified Fragment Length Polymorphism and PCR Ribotyping
J. Clin. Microbiol., March 1, 2004; 42(3): 1035 - 1041.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
H. Pituch, A. van Belkum, N. van den Braak, P. Obuch-Woszczatynski, H. Verbrugh, F. Meisel-Mikolajczyk, and M. Luczak
Recent Emergence of an Epidemic Clindamycin-Resistant Clone of Clostridium difficile among Polish Patients with C. difficile-Associated Diarrhea
J. Clin. Microbiol., September 1, 2003; 41(9): 4184 - 4187.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
G. Ackermann, A. Degner, S. H. Cohen, J. Silva Jr, and A. C. Rodloff
Prevalence and association of macrolide-lincosamide- streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile
J. Antimicrob. Chemother., March 1, 2003; 51(3): 599 - 603.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
K. A. Farrow, D. Lyras, and J. I. Rood
Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile
Microbiology, October 1, 2001; 147(10): 2717 - 2728.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
G. Whittle, B. D. Hund, N. B. Shoemaker, and A. A. Salyers
Characterization of the 13-Kilobase ermF Region of the Bacteroides Conjugative Transposon CTnDOT
Appl. Envir. Microbiol., August 1, 2001; 67(8): 3488 - 3495.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
H. Kato, N. Kato, K. Watanabe, T. Yamamoto, K. Suzuki, S. Ishigo, S. Kunihiro, I. Nakamura, G. E. Killgore, and S. Nakamura
Analysis of Clostridium difficile Isolates from Nosocomial Outbreaks at Three Hospitals in Diverse Areas of Japan
J. Clin. Microbiol., April 1, 2001; 39(4): 1391 - 1395.
[Abstract] [Full Text]


Home page
NEJMHome page
S. Johnson, M. H. Samore, K. A. Farrow, G. E. Killgore, F. C. Tenover, D. Lyras, J. I. Rood, P. DeGirolami, A. L. Baltch, M. E. Rafferty, et al.
Epidemics of Diarrhea Caused by a Clindamycin-Resistant Strain of Clostridium difficile in Four Hospitals
N. Engl. J. Med., November 25, 1999; 341(22): 1645 - 1651.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.